Nodexus

Nodexus is a private, early-revenue stage company founded in 2018 that has developed the NX One, a low-cost, benchtop microfluidic cell sorter. Its technology differentiates itself through ultra-gentle processing for high cell viability, a contamination-free disposable cartridge workflow, and a significantly lower price point than traditional fluorescence-activated cell sorting (FACS) systems. The company serves the research tools and diagnostics sectors, enabling applications from single-cell genomics and CRISPR workflows to organoid sorting and antibody development. Nodexus is positioned to democratize access to cell sorting technology for academic and biopharma labs with budget constraints.

Benchtop microfluidic cell sorting and dispensing system using disposable cartridges for gentle, contamination-free processing of particles from 2-200 microns.

Nodexus competes in the low-to-mid-range segment of the cell sorter market, challenging high-cost traditional FACS systems from BD Biosciences, Beckman Coulter, and Sony. It also faces competition from other benchtop and microfluidic sorters like those from Cytena (now part of BICO), On-chip Biotechnologies, and Union Biometrica (for large particles). Its main differentiation is the combination of sub-$100K price, gentle microfluidics, and specific capability for large particles/organoids.